1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Artificial Retina Market
2.2. Global Artificial Retina Market, By Artificial Retinas, 2023 (US$ Million)
2.3. Global Artificial Retina Market, By Retinal Degenerative Disease, 2023 (US$ Million)
2.4. Global Artificial Retina Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Artificial Retina Market: Competitive Analysis
3.1. Market Positioning of Key Artificial Retina Market Vendors
3.2. Strategies Adopted by Artificial Retina Market Vendors
3.3. Key Industry Strategies
4. Artificial Retina Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Artificial Retina Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Epiretinal implants
5.3.2. Sub retinal implants

6. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Age-related Macular Degeneration (AMD)
6.3.2. Retinitis Pigmentosa (RP)


7. North America Artificial Retina Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
7.3. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
7.4.Artificial Retina Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
7.4.1.1.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
7.4.1.2.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
7.4.1.3.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)

8. UK and European Union Artificial Retina Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.3. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
8.4.Artificial Retina Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.4.1.1.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.4.1.2.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.4.1.3.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.4.1.4.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.4.1.5.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
8.4.1.6.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)

9. Asia Pacific Artificial Retina Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.3. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
9.4.Artificial Retina Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.4.1.1.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.4.1.2.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.4.1.3.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.4.1.4.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.4.1.5.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
9.4.1.6.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)

10. Latin America Artificial Retina Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
10.3. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
10.4.Artificial Retina Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
10.4.1.1.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
10.4.1.2.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
10.4.1.3.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)

11. Middle East and Africa Artificial Retina Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
11.3. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
11.4.Artificial Retina Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
11.4.1.1.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
11.4.1.2.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Artificial Retina Market: By Artificial Retinas, 2022-2032, USD (Million)
11.4.1.3.2. Artificial Retina Market: By Retinal Degenerative Disease, 2022-2032, USD (Million)

12. Company Profile
12.1. Altris, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Axorus
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bionic Vision Technologies
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Labtician Ophthalmics, Inc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. LambdaVision, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Nano Retina
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Nidek Co., Ltd.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Optobionics
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Pixium Vision
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Vivani Medical Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Other Notable Players
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives